NAT9 Antikörper
-
- Target Alle NAT9 Produkte
- NAT9 (N-Acetyltransferase 9 (NAT9))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NAT9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purified
- Immunogen
- NAT9 antibody was raised using a synthetic peptide corresponding to a region with amino acids MRLNQNTLLLGKKVVLVPYTSEHVPSRYHEWMKSEELQRLTASEPLTLEQ
-
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
NAT9 Blocking Peptide, catalog no. 33R-6370, is also available for use as a blocking control in assays to test for specificity of this NAT9 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NAT9 antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- NAT9 (N-Acetyltransferase 9 (NAT9))
- Andere Bezeichnung
- NAT9 (NAT9 Produkte)
- Synonyme
- EBSP, hNATL antikoerper, 1110028N05Rik antikoerper, N-acetyltransferase 9 (putative) antikoerper, N-acetyltransferase 9 (GCN5-related, putative) antikoerper, NAT9 antikoerper, Nat9 antikoerper
- Hintergrund
- N-acetyltransferase 9 is an enzyme that in humans is encoded by the NAT9 gene.
- Molekulargewicht
- 23 kDa (MW of target protein)
-